FABRX is a specialist medtech company developing pharmaceutical 3D printing technology for the fabrication of medicines and medical devices. We enable the transition from manual compounding to automated, digitally controlled manufacturing of medicines within hospital pharmacies, research centres, and pharmaceutical environments.



Our M3DIMAKER pharmaceutical 3D printing ecosystem supports the production of multiple dosage forms with high precision, reproducibility, and GMP compliant processes. By digitising pharmaceutical compounding, FABRX helps improve medication safety, dosing accuracy, and workflow efficiency.



We focus on areas where standard medicines do not meet patient needs, including paediatrics, geriatrics, rare diseases, and precision medicine. Our technology allows healthcare professionals to move from adapting patients to medicines to adapting medicines to individual patient needs, enabling on demand manufacturing and flexible formulation.



Founded at the intersection of pharmaceutical science, digital health, and clinical practice, FABRX bridges research innovation with real world healthcare implementation. We collaborate closely with hospital pharmacists, researchers, and industry partners to bring advanced drug delivery, pharmaceutical automation, and digital manufacturing into routine clinical use.



Compounding Made Easy,

Print with the M3DIMAKER.